ARTICLE | Clinical News
Valrubicin cream: Phase IIa started
March 15, 2010 7:00 AM UTC
Valderm began a double-blind, placebo-controlled, international Phase IIa trial to compare 2 strengths of valrubicin cream applied once daily under occlusion vs. calcipotriol and betamethasone valerat...